Literature DB >> 28254122

Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.

Martin St John Sutton1, Cecilia Linde2, Michael R Gold3, William T Abraham4, Stefano Ghio5, Jeffrey Cerkvenik6, Jean-Claude Daubert7.   

Abstract

OBJECTIVES: This study sought to determine the effects of abnormal left ventricular (LV) architecture on cardiac remodeling and clinical outcomes in mild heart failure (HF).
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment for HF that improves survival in part by favorably remodeling LV architecture. LV shape is a dynamic component of LV architecture on which contractile function depends.
METHODS: Transthoracic 2-dimensional echocardiography was used to quantify changes in LV architecture over 5 years of follow-up of patients with mild HF from the REVERSE study. REVERSE was a prospective study of patients with large hearts (LV end-diastolic dimension ≥55 mm), LV ejection fraction <40%, and QRS duration >120 ms randomly assigned to CRT-ON (n = 419) and CRT-OFF (n = 191). CRT-OFF patients were excluded from this analysis. LV dimensions, volumes, mass index, and LV ejection fraction were calculated. LV architecture was assessed using the sphericity index, as follows: (LV end-diastolic volume)/(4/3 × π × r3) × 100%.
RESULTS: LV architecture improved over time and demonstrated significant associations between LV shape, age, sex, and echocardiography metrics. Changes in LV architecture were strongly correlated with changes in LV end-systolic volume index and LV end-diastolic volume index (both p < 0.0001). Sphericity index emerged as a predictor of death and HF hospitalization in spite of the low adverse event rate. A decrease in LV end-systolic volume index >15% occurred in more than two-thirds of patients, which indicates considerable reverse remodeling.
CONCLUSIONS: We demonstrated that change in LV architecture in patients with mild HF with CRT is associated with structural and functional remodeling. Mean LV filling pressure was elevated, and the inability to lower it was an additional predictor of HF hospitalization or death. (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction [REVERSE]; NCT00271154).
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  echocardiography; mild heart failure; pacemakers; remodeling

Mesh:

Year:  2017        PMID: 28254122     DOI: 10.1016/j.jchf.2016.11.012

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  8 in total

1.  Morphologic Analysis of the Normal Right Ventricle Using Three-Dimensional Echocardiography-Derived Curvature Indices.

Authors:  Karima Addetia; Francesco Maffessanti; Denisa Muraru; Amita Singh; Elena Surkova; Victor Mor-Avi; Luigi P Badano; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2018-02-21       Impact factor: 5.251

2.  Xin Fu Kang oral liquid inhibits excessive myocardial mitophagy in a rat model of advanced heart failure.

Authors:  Zhiling Qiu; Yuanhui Hu; Yanting Geng; Huaqin Wu; Rongqiang Bo; Jingjing Shi; Jiuchong Wang; Huan Wang
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

3.  Prediction efficiency of serum cystatin C for clinical outcome in patients with cardiac resynchronization therapy.

Authors:  Zhong-Bao Ruan; Ge-Cai Chen; Yin Ren; Li Zhu
Journal:  Ir J Med Sci       Date:  2018-02-24       Impact factor: 1.568

4.  Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies.

Authors:  Ghazaleh Mehdipoor; Shmuel Chen; Saurav Chatterjee; Pooya Torkian; Ori Ben-Yehuda; Martin B Leon; Gregg W Stone; Martin R Prince
Journal:  J Cardiovasc Magn Reson       Date:  2020-06-01       Impact factor: 5.364

5.  Prognostic value of reduction in left atrial size during a follow-up of heart failure: an observational study.

Authors:  Masayuki Shiba; Takao Kato; Takeshi Morimoto; Hidenori Yaku; Yasutaka Inuzuka; Yodo Tamaki; Neiko Ozasa; Yuta Seko; Erika Yamamoto; Yusuke Yoshikawa; Takeshi Kitai; Yugo Yamashita; Moritake Iguchi; Kazuya Nagao; Yuichi Kawase; Takashi Morinaga; Mamoru Toyofuku; Yutaka Furukawa; Kenji Ando; Kazushige Kadota; Yukihito Sato; Koichiro Kuwahara; Takeshi Kimura
Journal:  BMJ Open       Date:  2021-02-19       Impact factor: 2.692

6.  Global longitudinal strain and outcome after endoscopic mitral valve repair.

Authors:  Martin Kotrc; Jozef Bartunek; Jan Benes; Monika Beles; Marc Vanderheyden; Filip Casselman; Tomas Ondrus; Yujing Mo; Frank Van Praet; Martin Penicka
Journal:  ESC Heart Fail       Date:  2022-06-06

7.  Cardiac magnetic resonance defines mechanisms of sex-based differences in outcomes following cardiac resynchronization therapy.

Authors:  Derek J Bivona; Srikar Tallavajhala; Mohamad Abdi; Pim J A Oomen; Xu Gao; Rohit Malhotra; Andrew Darby; Oliver J Monfredi; J Michael Mangrum; Pamela Mason; Sula Mazimba; Michael Salerno; Christopher M Kramer; Frederick H Epstein; Jeffrey W Holmes; Kenneth C Bilchick
Journal:  Front Cardiovasc Med       Date:  2022-09-15

Review 8.  Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment.

Authors:  Riccardo M Inciardi; Andrea Bonelli; Tor Biering-Sorensen; Matteo Cameli; Matteo Pagnesi; Carlo Mario Lombardi; Scott D Solomon; Marco Metra
Journal:  Eur J Heart Fail       Date:  2022-06-06       Impact factor: 17.349

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.